Yuyu's Maxmavil Receives U.S. Patent

Published: 2005-01-12 06:58:00
Updated: 2005-01-12 06:58:00
Yuyu announced on January 10th that it has received the U.S. patent for Maxmavil, a novel combination anti-osteoporosis drug formulated with alendronate and calcitrol.

Maxmavil is the first novel combination drug by the domestic pharmaceutical industry, where it obtained the marketing approval...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.